ClinicalTrials.Veeva

Menu

RaDIANT Health Systems Intervention

Indiana University logo

Indiana University

Status

Invitation-only

Conditions

Kidney Disease
End Stage Renal Disease (ESRD)

Treatments

Other: Audit and Tracking of Patient Contact Attempts Prior to Referral Closure
Other: Phone Call to Dialysis Facility During the Patient's Dialysis Session
Other: Patient Contact via Preferred Method
Other: Performance Feedback Reports on Referral and Evaluation Closures
Other: Phone Call to Provider
Other: Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show
Other: Dialysis Facility Awareness Campaign

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07033117
18998 - Aim 2
R01DK136283 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.

Enrollment

14,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) ~800 referring dialysis center referring to these transplant centers

Exclusion criteria

  • Individuals referred, initiating evaluation, and waitlisted at non-participating start centers

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

14,000 participants in 1 patient group

Multi-Component Intervention
Experimental group
Description:
Five participating transplant centers will multicomponent intervention in their management of patients referred to their transplant center for a kidney transplantation. The intervention will consist of: (1) required performance feedback reports on closed referrals; and a set of optional components that may be implemented variably by centers, including; (2) contacting patients via their preferred method; (3) phone calls to the dialysis facility during the patient's dialysis session; (4) phone calls to the referring or other provider; (5) use of a multi-module, secure, web-enabled software application called Transplant Referral EXchange (T-REX) or secure email to communicate patient status and no-show information; and (6) communication tracking and audit. Dialysis facilities in GA, NC, SC, and IN will receive resources to support an awareness campaign to support implementation of intervention activities within transplant centers.
Treatment:
Other: Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show
Other: Dialysis Facility Awareness Campaign
Other: Phone Call to Provider
Other: Performance Feedback Reports on Referral and Evaluation Closures
Other: Patient Contact via Preferred Method
Other: Phone Call to Dialysis Facility During the Patient's Dialysis Session
Other: Audit and Tracking of Patient Contact Attempts Prior to Referral Closure

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems